Retail / Beauty · Deep dive

The Estée Lauder Companies Inc.

The New York prestige-beauty conglomerate whose $15.6B FY24 revenue collapsed to $14.3B in FY25 as Hainan travel-retail broke, whose 5,800-7,000-job restructuring (Feb 2025) and $1.2-1.6B in charges finally produced a 5%-reported / 3%-organic 'return to growth' in FY26 to $15.0B — but where challenger brands (Sol de Janeiro, Rare Beauty, Fenty, e.l.f.) keep taking prestige share, credit was cut by S&P and Moody's, and the Lauder-family Class B super-voting stack shields management from the activist pressure the multi-year numbers would otherwise trigger.

at risk

The China travel-retail engine that powered five years of compounding to a Jan 2022 stock high near $370 has structurally reset; the 5%-reported / 3%-organic FY26 'return to growth' comes only after 5,800-7,000 job cuts and $1.2-1.6B of restructuring charges, credit downgrades from S&P and Moody's, and it still leaves ELC ceding prestige shelf to Sol de Janeiro, Rare Beauty, Fenty and Charlotte Tilbury — with a Lauder-family Class B super-voting stack that keeps activist pressure off the ownership structure the numbers would otherwise force.

My take ★★ Very interesting ★ Interesting − Maybe ✗ Not interesting

Snapshot

The Estée Lauder Companies (NYSE: EL) is the New York prestige-beauty house behind Estée Lauder, MAC, Clinique, La Mer, Jo Malone, Le Labo, Tom Ford Beauty, Bobbi Brown, Aveda and Deciem (The Ordinary), among others. FY26 (year ended June 30, 2026) returned to growth at $15.0B (+5% reported, +3% organic), EPS $2.51 up 66% (elcompanies.com, Aug 19, 2026) — still below FY24’s $15.6B and well below the $17.7B FY22 peak, and only after a Feb 2025 expansion of the Profit Recovery and Growth Plan to 5,800-7,000 job cuts and $1.2-1.6B of charges. Stéphane de La Faverie became CEO on January 1, 2025 after Fabrizio Freda’s ~16-year tenure. S&P cut to A- (Oct 2024), Moody’s to A3 negative (Jan 2026). Stock ~$100.86 on Sept 3, 2026, off the Jan 2022 high near $370 by ~72%. Lauder family controls ~82% of the vote via 10:1 Class B super-voting stock.

Founding story

Estée Lauder was Josephine Esther Mentzer, born in Corona, Queens in 1908 to Hungarian-Jewish immigrants. She learned formulation from her uncle John Schotz, a Brooklyn chemist, then sold his creams from department-store counters through the mid-1940s, refining the free trial, personalised consultation and the gift-with-purchase — which she invented. She and husband Joseph incorporated Estée Lauder Cosmetics in a former restaurant kitchen in 1946; Saks placed an $800 order in 1947 that sold out in two days.

The company was built by son Leonard Lauder (joined 1958, CEO 1982) and taken public on the NYSE in Nov 1995 at $26, raising ~$450M+ (Encyclopedia.com; Invezz). The IPO preserved family control via a dual-class stack: Class B carries 10 votes to Class A’s one, giving the Lauders ~82% of the vote against a fraction of the economics (SEC DEF 14A). Every strategic decision since has been made under that governance. Leonard died in 2025; Ronald Lauder remains the largest individual Class B holder; William Lauder stepped down as Executive Chairman on Jan 1, 2025.

How it works

ELC sells through department stores (Nordstrom, Saks, Macy’s, Bloomingdale’s), specialty retail (Sephora, Ulta, Space NK, Douglas), travel retail (DFS, Dufry / Avolta), DTC and freestanding stores (MAC, Aveda, Jo Malone, Le Labo). Product is made across owned plants (Melville NY, Blaine MN, Oevel, Petersfield, Lachen) plus contract manufacturers; hero-SKU IP is proprietary. Unit economics: COGS 22-28%, marketing 25-30%, distribution 20-25%, operating margin 15-20% at peak. That works at an $80 lipstick or $475 serum. It breaks when e.l.f. sells a $9 dupe on TikTok, or when Sephora makes Sol de Janeiro its #1 top-selling brand across all categories.

Product and business overview

Skin care (~49% of FY25; $6.96B). Estée Lauder, La Mer, Clinique, Origins, Dr. Jart+, The Ordinary. +4% organic FY26. Makeup (~29%; $4.2B). MAC, Bobbi Brown, Estée Lauder color, Too Faced, Smashbox, Tom Ford color. Flat organic FY26; MAC and Tom Ford offset Bobbi Brown and Too Faced declines. Most exposed to Rare Beauty, Fenty, Charlotte Tilbury and e.l.f. Fragrance (~17%; $2.49B). Jo Malone, Le Labo, Tom Ford, Frédéric Malle, By Kilian, Kilian Paris. The winner — +10% organic FY26; Jo Malone and Tom Ford crossed the billion-dollar threshold. Hair care (~4%; $565M). Aveda, Bumble; Aveda review chatter since 2023.

Business model and pricing

Retail range: Clinique Dramatically Different $30-40, Advanced Night Repair $88-405, La Mer $210-2,100, Tom Ford lipstick $65-100, Le Labo Santal 33 $210-3,320. Revenue books when title passes to the retailer or DTC customer — FY24 was fundamentally a channel-inventory crisis. ELC booked shipments to Chinese travel-retail operators faster than Chinese consumers bought at the counter; the Hainan destocking cycle ran 2023 through FY25 and only turned in FY26. Class B super-voting shielded management from activist pressure during the collapse. The quarterly dividend was cut from $0.66 to $0.35 in November 2024. The $2.3B cash for Tom Ford (closed 2023) plus ~$1.7B for Deciem (through June 2024) hit the balance sheet just before the China / travel-retail air went out — the direct reason for the S&P downgrade to A- (Oct 2024) and Moody’s to A3 negative (Jan 2026).

Traction over time

FY26 geography: Americas $4.4B (+1%), EMEA $3.8B (+6%), APAC $3.7B (+4%), China ~$3.0B (+12%). FY27 guide: organic +3-5%; adjusted operating margin 12.7-13.5% — well below the ~19% FY22 peak.

Market analysis

Global prestige beauty ran ~$127B in 2023 heading to ~$180-190B by 2028 (Yahoo / Statista). Fragrance grew double-digits 2023-2025 as Gen-Z rediscovered scent; makeup is where challengers took share fastest. Three forces bear on ELC. Channel: department stores lost share to Sephora and Ulta, whose shelf allocation rewards TikTok velocity, not counter tradition. Geography: Chinese domestic prestige and Hainan / Korean travel retail — the 2017-2022 compounding engine — have reset lower and will not revisit prior peaks. Architecture: prestige is bifurcating into artisanal (Le Labo, Aesop, Byredo) at premium prices and mass-prestige dupe (e.l.f., The Ordinary, Rhode) at $8-30, squeezing the $40-100 core where MAC, Clinique and Estée Lauder color live.

Competitive intel

L’Oréal made the transition ELC did not — Luxe (Lancôme, YSL, Armani, Kiehl’s, Aesop) plus derm (CeraVe, La Roche-Posay, SkinCeuticals). LVMH controls both the challenger factory (Kendo: Fenty, Rare Beauty) and the retail rail (Sephora). Coty holds licensed prestige (Gucci, Burberry, Boss, Kylie). Puig — Charlotte Tilbury, Byredo, Rabanne, Carolina Herrera — IPO’d May 2024 with a family-control model mirroring the Lauders’ but wrapping a modern portfolio. Shiseido owns NARS and Drunk Elephant. e.l.f. bought Rhode for ~$1B in May 2025. Sol de Janeiro (L’Occitane) grew $39M (2019) to ~$950M (FY25), dethroning Rare Beauty as Sephora’s #1 in 2024. Rare Beauty printed >$400M in 2024. Amorepacific and P&G’s SK-II dominate the Asian prestige-skincare set La Mer wants.

History and evolution

• 1946 Lauders incorporate. 1947 Saks $800 order sells out in two days.
• 1964-82 Aramis, Clinique launched organically; Leonard becomes CEO 1982.
• 1994-98 MAC (~$60M all-in). Oct 1995 Bobbi Brown. Nov 1995 IPO at $26, ~$450M+ raised.
• 1997 Aveda ($300M). 1999 Jo Malone. 2000 Bumble. 2005 Tom Ford Beauty license. 2010 Smashbox. Oct 2014 Le Labo, Frédéric Malle, Rodin in one month. Dec 2016 Too Faced ($1.45B). 2017 initial Deciem stake.
• Jan 2022 stock high ~$370. Nov 15, 2022 Tom Ford brand at $2.8B EV, ~$2.3B cash; closed 1H 2023.
• Jun 2024 Deciem fully acquired (~$1.7B). Aug 2024 PRGP announced. Oct 30, 2024 de La Faverie named CEO from Jan 1, 2025; dividend cut $0.66 to $0.35; S&P to A-.
• Feb 4, 2025 Q2 FY25 -6%, $580M operating loss; PRGP expanded to 5,800-7,000 cuts, $1.2-1.6B charges. Aug 20, 2025 FY25 $14.3B, -8%. Jan 29, 2026 Moody’s to A3 negative.
• Aug 19, 2026 FY26 $15.0B +5% / +3% organic, EPS $2.51 (+66%); Jo Malone and Tom Ford join billion-dollar club.

What people say

The case for. Six billion-dollar brands after Tom Ford and Jo Malone crossed in FY26; fragrance +10% organic with Le Labo, Tom Ford and Kilian Paris structural winners in the Gen-Z scent boom; China +9% organic with value-share gains; margin expanded and diluted EPS grew 66%; FY27 adjusted operating margin guide raised to 12.7-13.5%; PRGP on track for $800M-$1B savings by FY27 (Retail Dive). Bernstein raised its target to $106 in 2026; JPMorgan stayed Overweight at $98 (Apr 2026, cut from $121).

The complaints. Revenue fell $17.7B (FY22) to $14.3B (FY25); FY26’s $15.0B still does not reach FY24. Q2 FY25’s $580M operating loss is the deepest print in company history (Forbes, Feb 2025). Glassdoor slipped to 3.5/5 across 6,401+ reviews, down 2% TTM; 56% would recommend, 38% have a positive outlook. Recurring themes: morale collapse, constant layoffs, no communication from senior leadership, extreme workloads on survivors, cultural drift. S&P (Oct 2024) cited leverage above 2x in FY26 after peaking mid-3x in FY25; Moody’s (Jan 2026) flagged tariff and PRGP execution risk. Sol de Janeiro’s $39M-to-$950M run and Rare Beauty’s >$400M plus Sephora #1 rank both happened at MAC’s, Bobbi Brown’s and Estée Lauder color’s expense on the same shelf.

Outlook: well positioned or at risk?

At-risk. FY26 does not undo the structural story. Hainan duty-free was down 10.8% in the first four months of 2025 (Bloomberg) after a 29.3% collapse in 2024; FY26’s +9% China organic comes off a lower base against stronger domestic Asian competition. The compounding engine that made ELC a $17.7B / ~19%-margin company in FY22 will not be rebuilt at that trajectory.

Second, shelf. Sol de Janeiro, Rare Beauty, Fenty, Charlotte Tilbury, e.l.f. and Rhode are compounding through the exact retailers (Sephora, Ulta) and channels (TikTok, Instagram, Amazon Beauty) that determine counter allocation. ELC’s answer — Le Labo, Tom Ford, Jo Malone — is working in fragrance but does not offset MAC and Bobbi Brown’s makeup losses.

Third, governance. Class B keeps activist pressure off. Any incumbent that went from $17.7B to $14.3B in three years, made a $2.3B acquisition at the peak, took $1.2-1.6B of restructuring charges and two credit downgrades would, in a normal structure, face a break-up campaign. Class B means the board could just swap the CEO. What flips the call: two more years of +5%+ organic at above-15% margin; a challenger-adjacent build; a Deciem-style acquisition of a Rhode or Ouai; and Lauder capital allocation shifting toward the categories actually growing. Absent that, a well-capitalised franchise printing recovery numbers on a permanently lower base with structurally smaller peak margins.

How to attack it

Build a TikTok-native prestige body / fragrance brand for Gen-Z and Gen-Alpha, priced $18-45, into Sephora within 12 months. The Sol de Janeiro playbook: a scented body-care hero (Bum Bum Cream), a distinctive olfactive signature (Cheirosa 62), accessible-prestige price, and a paid-plus-organic TikTok engine that turns try-ons into repeat purchase. Sol de Janeiro compounded $39M (2019) to $950M (FY25); Rare Beauty >$400M by 2024; Rhode sold to e.l.f. for ~$1B May 2025. Each attacked the exact counter space MAC, Bobbi Brown, Clinique color and Estée Lauder color sit in — from a cost structure ELC’s corporate stack cannot match.

Weaknesses: (1) revenue $17.7B (FY22) → $14.3B (FY25) with the peak unlikely to return; (2) Hainan down 10.8% in early 2025 after 29.3% collapse in 2024 (Bloomberg) — biggest historical growth engine structurally impaired; (3) 5,800-7,000 job cuts (Retail Dive, Feb 2025) and Glassdoor 3.5/5, “no communication from senior leadership” top theme — losing product and marketing talent; (4) S&P A- and Moody’s A3 negative limit acquisition firepower; (5) $2.3B cash on Tom Ford at the pre-collapse peak absorbed capital that would fund challenger response now; (6) FY26 makeup organic flat while Rare Beauty, Fenty, Charlotte Tilbury and e.l.f. compound double-digit; (7) department-store reliance in a Sephora-and-Ulta world; (8) Class B blocks the strategic responses — brand sales, break-up, PE carve-out — the numbers would otherwise force; (9) Aveda / Bumble ($565M FY25) a review candidate since 2023 with no action; (10) $40-100 architecture squeezed by dupes and artisanal super-premium from both sides.

Adjacent-segment play

The adjacent play is contract manufacturing plus formulation-IP licensing for indie prestige brands — the reverse of the acquisition model. ELC owns some of the best-known formulations (Advanced Night Repair, Miracle Broth, Clinique Dramatically Different), best plants and deepest fragrance benches (Le Labo, Kilian, Frédéric Malle). A structured platform could sell those assets to the TikTok-native indies eating ELC’s shelf. Cosmetic Solutions, Kolmar Korea and Cosmax do this at scale for Korean prestige; no US / EU parallel exists at prestige quality. Second, wellness and longevity: La Mer at $2,100 a jar is already priced in the aesthetic-medicine range; a push into ingestibles, IV drips, HRT-adjacent skincare and clinic partnerships would compete with L’Oréal’s aesthetics business and Galderma. Third, male grooming as prestige: Aramis is dormant; a modern Aramis in the Byredo / Le Labo unisex space is a $200-500M brand. Execution is limited only by whether Lauder governance lets the parent look unlike what Estée herself built.

Sources and further reading

• ELC Reports Fiscal 2026 Results — ELC, Aug 19, 2026.
• ELC Reports Fiscal 2025 Results — ELC, Aug 20, 2025.
• De La Faverie named CEO — ELC, Oct 30, 2024.
• De La Faverie Reinvention Strategy — WWD, 2025.
• Massive Job Cuts, Up To 11% — Forbes, Feb 5, 2025.
• Up to 10K role reductions — Retail Dive, 2025.
• China Duty-Free Falls — Bloomberg, May 21, 2025.
• Tom Ford brand acquisition US$2.8B — Moodie Davitt Report, Nov 15, 2022.
• Deciem acquisition completed — ELC, Jun 3, 2024.
• S&P Global downgrade — S&P via Investing.com, Oct 2024.
• Moody’s downgrade — Moody’s via Investing.com, Jan 2026.
• EL revenue 2005-2026 — stockanalysis.com.
• ELC — Glassdoor — Glassdoor, Sept 2026.
• Sol de Janeiro sales — Statista — Statista.